Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Future Cardiology|July 2, 2024
The influence of P2Y12 gene polymorphisms on clopidogrel therapy in patients after percutaneous coronary interventionKornel Pawlak, Dorota Danielak, Paweł Burchardt, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 25, 2024
Drug dissolution and transit in a heterogenous gastric chyme after fed administration: Semi-mechanistic modeling and simulations for an immediate-release and orodispersible tablets containing a poorly soluble drugDorota Danielak, Maciej Gajda, Tomasz Bołtromiuk, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 30, 2018
Relationship between exposure to treosulfan and its monoepoxytransformer - An insight from population pharmacokinetic study in pediatric patients before hematopoietic stem cell transplantationDorota Danielak, Anna Kasprzyk, Tomasz Wróbel, et al.
European Journal of Clinical Pharmacology|October 5, 2017
Population pharmacokinetics of treosulfan and development of a limited sampling strategy in children prior to hematopoietic stem cell transplantationDorota Danielak, Jadwiga Twardosz, Anna Kasprzyk, et al.
Journal of Clinical Pharmacology|May 1, 2014
The influence of genetic polymorphism of Cyp2c19 isoenzyme on the pharmacokinetics of clopidogrel and its metabolites in patients with cardiovascular diseasesMarta Karaźniewicz-Łada, Dorota Danielak, Błażej Rubiś, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 11, 2012
HPLC-MS/MS method for the simultaneous determination of clopidogrel, its carboxylic acid metabolite and derivatized isomers of thiol metabolite in clinical samplesMarta Karaźniewicz-Łada, Dorota Danielak, Artur Teżyk, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|April 4, 2023
Conjunction of semi-mechanistic in vitro-in vivo modeling and population pharmacokinetics as a tool for virtual bioequivalence analysis - a case study for a BCS class II drugDorota Danielak, Jadwiga Paszkowska, Marcela Staniszewska, et al.
AAPS Pharmscitech|February 14, 2023
PhysioCell®; - a Novel, Bio-relevant Dissolution Apparatus: Hydrodynamic Conditions and Factors Influencing the Dissolution DynamicsMarcela Staniszewska, Michał Romański, Justyna Dobosz, et al.
European Journal of Drug Metabolism and Pharmacokinetics|February 20, 2016
Impact of CYP3A4*1G Allele on Clinical Pharmacokinetics and Pharmacodynamics of ClopidogrelDorota Danielak, Marta Karaźniewicz-Łada, Karolina Wiśniewska, et al.
Clinical Pharmacokinetics|October 16, 2013
Clinical pharmacokinetics of clopidogrel and its metabolites in patients with cardiovascular diseasesMarta Karaźniewicz-Łada, Dorota Danielak, Paweł Burchardt, et al.
Pageof 4